Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
The Netherlands Journal of Medicine
|
January 1, 1986
New prospects for immune status assessment in Hodgkin's disease
R E Van Rijswijk
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1992
Suramin awakes?
H M Pinedo, R E van Rijswijk
Drugs & Aging
|
August 10, 2000
Drug therapy for gynaecological cancer in older women
R E van Rijswijk, J B Vermorken
Cancer
|
January 1, 1984
A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease
R E van Rijswijk, J P Sybesma, L Kater
Cancer
|
February 15, 1983
A prospective study of the changes in the immune status before, during, and after multiple-agent chemotherapy for Hodgkin's disease
R E Van Rijswijk, J P Sybesma, L Kater
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
A case of brain metastases from male breast cancer responding to tamoxifen
R E van Rijswijk, R J van Oostenbrugge, A Twijnstra
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 1, 1996
A clarithromycin-induced myasthenic syndrome
E Pijpers, R E van Rijswijk, B Takx-Köhlen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Workshop on suramin with emphasis on prostate cancer: re-evaluation of response criteria
R E van Rijswijk, E Cvitkovic, J Wagstaff, et al.
Cancer
|
April 15, 1986
Five-year survival in Hodgkin's disease. The prospective value of immune status at diagnosis
R E van Rijswijk, A de Meijer, J P Sybesma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 1998
Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease
R E van Rijswijk, K Hoekman, C W Burger, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
The Netherlands Journal of Medicine
|
January 1, 1986
New prospects for immune status assessment in Hodgkin's disease
R E Van Rijswijk
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1992
Suramin awakes?
H M Pinedo, R E van Rijswijk
Drugs & Aging
|
August 10, 2000
Drug therapy for gynaecological cancer in older women
R E van Rijswijk, J B Vermorken
Cancer
|
January 1, 1984
A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease
R E van Rijswijk, J P Sybesma, L Kater
Cancer
|
February 15, 1983
A prospective study of the changes in the immune status before, during, and after multiple-agent chemotherapy for Hodgkin's disease
R E Van Rijswijk, J P Sybesma, L Kater
European Journal of Cancer (Oxford, England : 1990)
|
February 21, 1998
A case of brain metastases from male breast cancer responding to tamoxifen
R E van Rijswijk, R J van Oostenbrugge, A Twijnstra
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 1, 1996
A clarithromycin-induced myasthenic syndrome
E Pijpers, R E van Rijswijk, B Takx-Köhlen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Workshop on suramin with emphasis on prostate cancer: re-evaluation of response criteria
R E van Rijswijk, E Cvitkovic, J Wagstaff, et al.
Cancer
|
April 15, 1986
Five-year survival in Hodgkin's disease. The prospective value of immune status at diagnosis
R E van Rijswijk, A de Meijer, J P Sybesma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 13, 1998
Experience with intraperitoneal cisplatin and etoposide and i.v. sodium thiosulphate protection in ovarian cancer patients with either pathologically complete response or minimal residual disease
R E van Rijswijk, K Hoekman, C W Burger, et al.
Page
of 3